217 related articles for article (PubMed ID: 8286546)
1. Distinction between Aujeszky's disease virus-infected and vaccinated pigs by hemagglutination-inhibition test.
Shibata I; Uruno K; Samegai Y; Inaba Y
J Vet Med Sci; 1993 Oct; 55(5):859-61. PubMed ID: 8286546
[TBL] [Abstract][Full Text] [Related]
2. Sensitive glycoprotein gIII blocking ELISA to distinguish between pseudorabies (Aujeszky's disease)-infected and vaccinated pigs.
Kit M; Kit S
Vet Microbiol; 1991 Jul; 28(2):141-55. PubMed ID: 1651582
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay.
van Oirschot JT; Rziha HJ; Moonen PJ; Pol JM; van Zaane D
J Gen Virol; 1986 Jun; 67 ( Pt 6)():1179-82. PubMed ID: 3011974
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity in Aujeszky's disease virus structural glycoprotein gVI (gp50) in swine.
Mukamoto M; Watanabe I; Kobayashi Y; Icatlo FC; Ishii H; Kodama Y
Vet Microbiol; 1991 Oct; 29(2):109-21. PubMed ID: 1660638
[TBL] [Abstract][Full Text] [Related]
5. Development of an ELISA to differentiate between animals either vaccinated with or infected by Aujeszky's disease virus.
Eloit M; Fargeaud D; Vannier P; Toma B
Vet Rec; 1989 Jan; 124(4):91-4. PubMed ID: 2538951
[TBL] [Abstract][Full Text] [Related]
6. Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes.
Kit S; Sheppard M; Ichimura H; Kit M
Am J Vet Res; 1987 May; 48(5):780-93. PubMed ID: 3035972
[TBL] [Abstract][Full Text] [Related]
7. Safety of an Aujeszky's disease vaccine based on deletion mutant strain 783 which does not express thymidine kinase and glycoprotein I.
van Oirschot JT; Terpstra C; Moormann RJ; Berns AJ; Gielkens AL
Vet Rec; 1990 Nov; 127(18):443-6. PubMed ID: 2177288
[TBL] [Abstract][Full Text] [Related]
8. Development of an ELISA for detection of antibodies to glycoprotein I of Aujeszky's disease virus: a method for the serological differentiation between infected and vaccinated pigs.
van Oirschot JT; Houwers DJ; Rziha HJ; Moonen PJ
J Virol Methods; 1988 Dec; 22(2-3):191-206. PubMed ID: 2851599
[TBL] [Abstract][Full Text] [Related]
9. Blocking ELISA to distinguish pseudorabies virus-infected pigs from those vaccinated with a glycoprotein gIII deletion mutant.
Kit S; Awaya Y; Otsuka H; Kit M
J Vet Diagn Invest; 1990 Jan; 2(1):14-23. PubMed ID: 1965296
[TBL] [Abstract][Full Text] [Related]
10. A novel concept for the control of Aujeszky's disease: experiences in two vaccinated pig herds.
van Oirschot JT; Wijsmuller JM; de Waal CA; van Lith PM
Vet Rec; 1990 Feb; 126(7):159-63. PubMed ID: 2155499
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of antibodies of field pseudorabies virus in pigs of herd vaccinated with live vaccine.
Asai T; Tajima M; Watanabe H; Shibata I
J Vet Med Sci; 1998 Mar; 60(3):399-400. PubMed ID: 9560796
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of specific humoral immune response in pigs vaccinated intradermally with deleted Aujeszky's disease vaccine and challenged with virulent strain of Herpesvirus suis type 1.
Mikulska-Skupień E; Szweda W; Procajło Z
Pol J Vet Sci; 2005; 8(1):11-6. PubMed ID: 15794468
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of swinepox virus as a vaccine vector in pigs using an Aujeszky's disease (pseudorabies) virus gene insert coding for glycoproteins gp50 and gp63.
van der Leek ML; Feller JA; Sorensen G; Isaacson W; Adams CL; Borde DJ; Pfeiffer N; Tran T; Moyer RW; Gibbs EP
Vet Rec; 1994 Jan; 134(1):13-8. PubMed ID: 8128561
[TBL] [Abstract][Full Text] [Related]
14. An ELISA to distinguish between Aujeszky's disease vaccinated and infected pigs.
van Oirschot JT; de Waal CA
Vet Rec; 1987 Sep; 121(13):305-6. PubMed ID: 2827365
[No Abstract] [Full Text] [Related]
15. Potency of an experimental DNA vaccine against Aujeszky's disease in pigs.
Gerdts V; Jöns A; Mettenleiter TC
Vet Microbiol; 1999 Mar; 66(1):1-13. PubMed ID: 10223318
[TBL] [Abstract][Full Text] [Related]
16. [Trial of vaccination against Aujeszky's disease].
Motovski A; Veselinova A; Dobrev V
Vet Med Nauki; 1980; 17(5):32-7. PubMed ID: 6262995
[TBL] [Abstract][Full Text] [Related]
17. gIII antibody responses in pigs following vaccination and challenge to Aujeszky's disease.
Motha MX; Ralston JC
Vet Microbiol; 1991 Apr; 27(2):197-201. PubMed ID: 1648283
[TBL] [Abstract][Full Text] [Related]
18. Induction of antibodies to glycoprotein I in pigs exposed to different doses of a mildly virulent strain of Aujeszky's disease virus.
van Oirschot JT
Vet Rec; 1988 Jun; 122(25):599-603. PubMed ID: 2841789
[TBL] [Abstract][Full Text] [Related]
19. Influence of vaccination route on the efficacy of Aujeszky's disease deletion-mutant vaccine.
Hasebe H; Osorio FA; Hogg A; Liauw H; Bartkoski MJ; Sugiyama M
J Vet Med Sci; 1992 Aug; 54(4):693-8. PubMed ID: 1327180
[TBL] [Abstract][Full Text] [Related]
20. Constancy of Aujeszky's field virus antibody titres in sows repeatedly vaccinated with a gI-negative vaccine.
Hopp W; Jungblut R
Acta Vet Hung; 1994; 42(2-3):409-11. PubMed ID: 7810439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
